Patent details

91279 Product Name: "Tigécycline et ses dérivés pharmaceutiquement acceptables - Tygacil®"

Basic Information

Publication number:
91279
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP921142816
Legal Status:
Expired
Application number:
91279
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
30/07/2015
SPC Extension Agent Name:
OFFICE FREYLINGER S.A. , WYETH HOLDINGS LLC
SPC Extension Status:
Granted
SPC Extension Grant Date:
23/12/2016
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/06/336/001
Marketing Authorization Type:
Marketing Authorization Date:
24/04/2006
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
11/10/2006
First Marketing Authorization date:
24/04/2006
Grant date:
11/12/2006
Activation date:
21/08/2012
Publication date:
11/12/2006
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
21/08/2017
SPC Extension Expiration:
21/02/2018
Rejection date:
Withdrawal date:

Owner

From:
20/05/2015
 
 

Name:
WYETH HOLDINGS LLC
Address:
235 EAST 42ND STREET, NEW YORK, NY 10017, United States (US)

History of Owners

From:
11/10/2006
To:
19/05/2015

Name:
WYETH HOLDINGS CORPORATION
Address:
GIRALDA FARMS 5, MADISON, NEW JERSEY 07940-0874, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/10/2006
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Gluzman Yakov
Address:
United States (US)

2

Name:
Ross Adma A.
Address:
United States (US)

3

Name:
Hlavka Joseph J.
Address:
United States (US)

4

Name:
Sum Phaik-Eng
Address:
United States (US)

5

Name:
Lee Ving J.
Address:
United States (US)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
12/07/2016
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages